Compliance
In accordance with the Government of India’s Department of Pharmaceuticals notification under the Uniform Code for Marketing Practices in Medical Devices (UCMPMD) 2024 Guidelines, we are disclosing details related to free samples distributed, marketing expenses incurred directly by the company, and those incurred through third parties, including medical associations and bodies.
You can download the disclosure document below to review these details.
Marketing Expenditure Sheet 2024–25